Cangrelor and Stenting in Acute Ischemic Stroke : Monocentric Case Series.
Mahmoud ElhoranyStephanie LenckVincent DegosNader-Antoine SourourGiulia Frasca PolaraEimad ShotarAnne GodierMehdi DrirJugurtha MahtoutKevin PrematSonia AlamowitchYves SamsonFrederic ClarenconPublished in: Clinical neuroradiology (2020)
Cangrelor might be a safe and effective antiplatelet medication owing to its on/off activity for acute stenting in the setting of acute ischemic stroke. Further investigations through randomized studies with larger samples are necessary.
Keyphrases
- acute ischemic stroke
- antiplatelet therapy
- liver failure
- double blind
- open label
- respiratory failure
- placebo controlled
- healthcare
- phase iii
- acute coronary syndrome
- drug induced
- percutaneous coronary intervention
- phase ii
- aortic dissection
- case control
- adverse drug
- clinical trial
- emergency department
- coronary artery disease